000 | 01678 a2200433 4500 | ||
---|---|---|---|
005 | 20250516064117.0 | ||
264 | 0 | _c20120413 | |
008 | 201204s 0 0 eng d | ||
022 | _a1879-114X | ||
024 | 7 |
_a10.1016/j.clinthera.2011.10.023 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChristensen, Abeline | |
245 | 0 | 0 |
_aRoom-temperature-stable recombinant activated coagulation factor VII recombinant: chemical and microbiologic stability over 24 hours during continuous in vitro infusion. _h[electronic resource] |
260 |
_bClinical therapeutics _cDec 2011 |
||
300 |
_a1997-2001 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
650 | 0 | 4 | _aBlood Coagulation Tests |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aChromatography, Gel |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aChromatography, Reverse-Phase |
650 | 0 | 4 |
_aCoagulants _xadministration & dosage |
650 | 0 | 4 |
_aDrug Contamination _xprevention & control |
650 | 0 | 4 |
_aDrug Delivery Systems _xinstrumentation |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aFactor VIIa _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 | _aSyringes |
650 | 0 | 4 | _aTemperature |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aJensen, Jane T | |
700 | 1 | _aNøhr, Anne Mette | |
700 | 1 | _aCooper, David L | |
773 | 0 |
_tClinical therapeutics _gvol. 33 _gno. 12 _gp. 1997-2001 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clinthera.2011.10.023 _zAvailable from publisher's website |
999 |
_c21316345 _d21316345 |